Evidence map›Paper›PMID 42621209›Full record

ArticleCase reports in critical care2026

Life-Threatening Bupropion Poisoning Successfully Treated by Intravenous Lipid Emulsion.

Francesca Chiara Della Casa, Vincent Haufroid, Kevin Delongie, Thomas Coppens, Ester Ponzetto, Nicolas De Schryver

Abstract read
In one paragraph

Article in Case reports in critical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Francesca Chiara Della CasaIntensive Care Unit, Saint-Pierre Hospital, Ottignies-Louvain-la-Neuve, Belgium.ORCID https://orcid.org/0009-0009-7193-8622
Vincent HaufroidDepartment of Clinical Chemistry, Saint-Luc University Hospital, Brussels, Belgium, saintluc.be.ORCID https://orcid.org/0000-0001-5040-9806
Kevin DelongieDepartment of Clinical Chemistry, Saint-Luc University Hospital, Brussels, Belgium, saintluc.be.
Thomas CoppensDepartment of Neurology, Saint-Pierre Hospital, Ottignies-Louvain-la-Neuve, Belgium.ORCID https://orcid.org/0009-0003-2420-573X
Ester PonzettoIntensive Care Unit, Saint-Pierre Hospital, Ottignies-Louvain-la-Neuve, Belgium.
Nicolas De SchryverIntensive Care Unit, Saint-Pierre Hospital, Ottignies-Louvain-la-Neuve, Belgium.ORCID https://orcid.org/0000-0003-4584-0903

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bupropion is a synthetic cathinone that acts as a norepinephrine and dopamine reuptake inhibitor and is an atypical antidepressant commonly prescribed for major depressive disorder and smoking cessation. Although generally well tolerated at therapeutic doses, bupropion overdose can lead to severe toxicity, primarily characterized by seizures and cardiac arrhythmias. Management of severe intoxications remains mainly supportive, with no specific antidote available. Intravenous lipid emulsion (ILE) therapy has emerged as a potential treatment for poisoning with highly lipophilic drugs. Initially found to reverse local anesthetic toxicity, ILE is hypothesized to work via multiple mechanisms, including a "lipid shuttle" effect and direct stabilization of highly excitable membranes in the brain and heart. However, its precise role in nonanesthetic drug intoxications remains incompletely understood. We report a case of a massive, intentional bupropion overdose (24,000 mg) in a patient with no coingestion of other toxic substances aside from alcohol. The patient developed refractory seizures and severe ventricular arrhythmias, which were successfully reversed after ILE administration. Serial blood measurements of bupropion and its metabolites were performed before and after ILE administration, supporting both lipid sequestration of the drug and direct cardioprotective effects. A preprint of this study is available online (Della Casa et al. 2026).

Indexed as

bupropionintravenous lipid emulsionpoisoning

Identifiers

PMID42621209
PMCPMC13486964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.